Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2012
11/15/2012US20120289536 Pharmaceutical Compositions Comprising Colloidal Silicon Dioxide
11/15/2012US20120289535 Dual phase drug release system
11/15/2012US20120289534 Package for improved treatment of conditions
11/15/2012US20120289533 Use of Manzamine Compounds in Anti-Cancer Therapeutic Regimens
11/15/2012US20120289532 Method for the production of amorphous rifaximin
11/15/2012US20120289531 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289530 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289529 Combinations of trospium and salivary stimulants for the treatment of overactive bladder
11/15/2012US20120289528 Method of treating proliferative disorders and other pathological conditions mediated by bcr-abl, c-kit, ddr1, ddr2 or pdgf-r kinase activity
11/15/2012US20120289527 Mono-hydrochloric salts of an inhibitor of histone deacetylase
11/15/2012US20120289526 Imidazolidinedione derivatives
11/15/2012US20120289525 Pyrimidine ether derivatives and methods of use thereof
11/15/2012US20120289524 Pyrrolo [3,2-e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation
11/15/2012US20120289523 Pyrrolo [3,2-e] [1,2,4] triazolo [1,5-a] pyrimidines derivatives as inhibitors of microglia activation
11/15/2012US20120289522 Compounds as lysophosphatidic acid receptor antagonists
11/15/2012US20120289521 Treatment of Acne and Other Diseases
11/15/2012US20120289520 Chemical compounds 785
11/15/2012US20120289519 Protease inhibitors
11/15/2012US20120289518 Derivatives of 2-oxoalkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same
11/15/2012US20120289517 Solid pharmaceutical composition for oral administration
11/15/2012US20120289516 Methods for Administering Aripiprazole
11/15/2012US20120289515 Combination therapy for cognitive distortions, resisting relapse of unipolar non-psychotic depression
11/15/2012US20120289514 Pharmaceutical composition for treating alcohol dependency
11/15/2012US20120289513 (4-tert-butylpiperazin-2-yl)(piperazin-1-yl)methanone-n-carboxamide derivatives
11/15/2012US20120289512 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
11/15/2012US20120289511 Compositions and methods for treating alzheimer's disease
11/15/2012US20120289510 Benzyl Amines, A Process For Their Production And Their Use As Anti-Inflammtory Agents
11/15/2012US20120289509 Heterocyclic compound as protein kinase inhibitor
11/15/2012US20120289508 Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
11/15/2012US20120289507 Organic compounds as smo inhibitors
11/15/2012US20120289506 5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
11/15/2012US20120289505 Inhibitors of diacylglycerol acyl transferase
11/15/2012US20120289504 Benzoimidazole Compounds and Uses Thereof
11/15/2012US20120289503 Aqueous solution comprising 3 - quinuclidinones for the treatment hyperproliferative, autoimmune and heart disease
11/15/2012US20120289502 Imidazole derivatives
11/15/2012US20120289501 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls
11/15/2012US20120289500 Potassium channel modulators
11/15/2012US20120289499 Process
11/15/2012US20120289498 Compositions And Methods Relating To Novel Compounds And Targets Thereof
11/15/2012US20120289497 Fused pyridine derivatives
11/15/2012US20120289496 Novel compounds as modulators of protein kinases
11/15/2012US20120289495 Compounds and methods
11/15/2012US20120289494 Spiro-oxindole mdm2 antagonists
11/15/2012US20120289493 Fused heterocyclic compounds as ion channel modulators
11/15/2012US20120289492 Methods of treating mitochondrial disorders using metalloporphyrins
11/15/2012US20120289491 Methods for the treatment of a central nervous system injury via a tapered administration protocol
11/15/2012US20120289490 Compositions and methods for enhancing corticosteroid delivery
11/15/2012US20120289489 Non-sedating antihistamine injection formulations and methods of use thereof
11/15/2012US20120289488 Steroid-Sparing Effects of Beta-Adrenergic Inverse Agonists and Uses Thereof
11/15/2012US20120289487 Pharmaceutical Use of Multicyclic Compounds as Anti-Aids Agents
11/15/2012US20120289486 Treatment of eyelid dermatitis
11/15/2012US20120289485 Metformin Salts of Salicylic Acid and Its Congeners
11/15/2012US20120289484 Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and methods of using the same
11/15/2012US20120289483 Compounds for the treatment of proliferative disorders
11/15/2012US20120289482 Method for modulating or controlling connexin 43(Cx43) level of a cell and reducing arrhythmic risk
11/15/2012US20120289481 Compositions and methods for treating cancer
11/15/2012US20120289480 Cyclodextrin-based polymers for therapeutics delivery
11/15/2012US20120289479 Materials and Methods Related to Sodium/Potassium Adenosine Triphosphate and Cholesterol
11/15/2012US20120289478 Hyaluronic acid esters, their preparation and use in dermatology
11/15/2012US20120289477 Biotechnological sulphated chondroitin sulphate at position 4 or 6 on the same polysaccharide chain, and process for the preparation thereof
11/15/2012US20120289476 Methods for treating methylmalonic acidemia
11/15/2012US20120289475 Certain Compounds, Compositions and Methods
11/15/2012US20120289474 3,4,4A,10B-TETRAHYDRO-1H-THIOPYRANO-[4,3-c] ISOQUINOLINE DERIVATIVES
11/15/2012US20120289473 Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water-soluble extract from plant of solanum genus
11/15/2012US20120289471 Novel compounds with high therapeutic index
11/15/2012US20120289470 Transmucosal administration of drug compositions for treating and preventing disorders in animals
11/15/2012US20120289469 Methods and compositions for maintaining active agents in intra-articular spaces
11/15/2012US20120289463 Compositions and Methods for Promoting Epithelialization and Wound Closure
11/15/2012US20120289452 Compositions and methods for treating and preventing necrosis
11/15/2012US20120288931 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/15/2012US20120288712 Escitalopram and solid pharmaceutical composition comprising the same
11/15/2012US20120288579 Use of lignan compound for anti-wrinkle treatment
11/15/2012US20120288575 Cleanser compositions and methods for using the same
11/15/2012US20120288573 Use of extracts from salonum glaucophyllum for treating bone metabolism disorders and kidney disorders
11/15/2012US20120288569 Parenteral administration of pyrophosphate for prevention or treatment of phosphate or pyrophosphate depletion
11/15/2012US20120288568 Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (rbp), and/or serum retinol-rbp modulation
11/15/2012US20120288567 Opioid Agonist Formulations with Releasable And Sequestered Antagonist
11/15/2012US20120288566 Liquid precursor compositions and uses thereof for a ph-dependant sustained release treatment of oral disorders
11/15/2012US20120288565 Tamper-resistant oral opioid agonist formulations
11/15/2012US20120288563 Amorphous darunavir
11/15/2012US20120288562 Acid Resistant Capsules
11/15/2012US20120288561 Delayed-release formulation for reducing the frequency of urination and method of use thereof
11/15/2012US20120288560 Methods for the Treatment of CNS-Related Conditions
11/15/2012US20120288559 Organic compounds
11/15/2012US20120288558 Method for administration of pegylated liposomal doxorubicin
11/15/2012US20120288557 Acoustically sensitive drug delivery particles comprising low concentrations of phosphatidylethanolamine
11/15/2012US20120288556 Ceramide anionic liposome compositions
11/15/2012US20120288555 Antiproliferative compositions comprising curcumin analogs and methods of producing and using same
11/15/2012US20120288554 Canfosfamide monotherapy for treating multiple myeloma
11/15/2012US20120288551 Implantable Polymeric Device for Sustained Release of Sufentanil
11/15/2012US20120288544 Novel retigabine composition
11/15/2012US20120288543 Wet Granulation Using A Water Sequestering Agent
11/15/2012US20120288542 Solid pharmaceutical dispersions with enhanced bioavailability
11/15/2012US20120288541 Drug Loaded Polymeric Nanoparticles and Methods of Making and Using Same
11/15/2012US20120288536 Stabilized Stat3 Decoy Oligonucleotides And Uses Therefor
11/15/2012US20120288534 Corticosteroids for the Treatment of Joint Pain
11/15/2012US20120288533 Protein-polysaccharide conjugates and use for encapsulating nutraceuticals for clear beverage applications
11/15/2012US20120288532 Multi-layered, multiple unit pharmaceutical compositions
11/15/2012US20120288531 pharmaceutical compositions for delivery of ferric iron compounds, and methods of use thereof
11/15/2012US20120288529 Pharmaceutical excipient, method for its preparation and use thereof
1 ... 956 957 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 ... 7860